Previous reports showed that MMP13 could regulate tumor aggressiveness in oral cancer via the HBP1-MMP13 axis and can act as a diagnostic and prognostic molecular marker in HNSCC [38]. This evidence concerns the gene HBP1 and lip and oral cavity carcinoma.